19-50329060-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_001372305.1(KCNC3):c.-206C>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000131 in 1,311,688 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00022 ( 1 hom., cov: 22)
Exomes 𝑓: 0.00012 ( 1 hom. )
Consequence
KCNC3
NM_001372305.1 5_prime_UTR_premature_start_codon_gain
NM_001372305.1 5_prime_UTR_premature_start_codon_gain
Scores
2
2
15
Clinical Significance
Conservation
PhyloP100: 1.40
Genes affected
KCNC3 (HGNC:6235): (potassium voltage-gated channel subfamily C member 3) The Shaker gene family of Drosophila encodes components of voltage-gated potassium channels and is comprised of four subfamilies. Based on sequence similarity, this gene is similar to one of these subfamilies, namely the Shaw subfamily. The protein encoded by this gene belongs to the delayed rectifier class of channel proteins and is an integral membrane protein that mediates the voltage-dependent potassium ion permeability of excitable membranes. Alternate splicing results in several transcript variants. [provided by RefSeq, Mar 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.069700986).
BP6
Variant 19-50329060-G-C is Benign according to our data. Variant chr19-50329060-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 447623.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=2, Benign=2}.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000215 (30/139386) while in subpopulation EAS AF= 0.00416 (17/4082). AF 95% confidence interval is 0.00265. There are 1 homozygotes in gnomad4. There are 7 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck.
BS2
High AC in GnomAd4 at 30 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNC3 | NM_004977.3 | c.23C>G | p.Ser8Trp | missense_variant | 1/5 | ENST00000477616.2 | NP_004968.2 | |
KCNC3 | NM_001372305.1 | c.-206C>G | 5_prime_UTR_premature_start_codon_gain_variant | 1/5 | NP_001359234.1 | |||
KCNC3 | NM_001372305.1 | c.-206C>G | 5_prime_UTR_variant | 1/5 | NP_001359234.1 | |||
KCNC3 | NR_110912.2 | n.68+4409C>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNC3 | ENST00000477616.2 | c.23C>G | p.Ser8Trp | missense_variant | 1/5 | 1 | NM_004977.3 | ENSP00000434241.1 | ||
KCNC3 | ENST00000670667.1 | c.23C>G | p.Ser8Trp | missense_variant | 1/4 | ENSP00000499301.1 | ||||
KCNC3 | ENST00000376959.6 | c.23C>G | p.Ser8Trp | missense_variant | 1/5 | 5 | ENSP00000366158.2 | |||
KCNC3 | ENST00000474951.1 | c.-75+4409C>G | intron_variant | 2 | ENSP00000432438.1 |
Frequencies
GnomAD3 genomes AF: 0.000215 AC: 30AN: 139268Hom.: 1 Cov.: 22
GnomAD3 genomes
AF:
AC:
30
AN:
139268
Hom.:
Cov.:
22
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000983 AC: 6AN: 61032Hom.: 0 AF XY: 0.0000838 AC XY: 3AN XY: 35816
GnomAD3 exomes
AF:
AC:
6
AN:
61032
Hom.:
AF XY:
AC XY:
3
AN XY:
35816
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000121 AC: 142AN: 1172302Hom.: 1 Cov.: 20 AF XY: 0.000101 AC XY: 58AN XY: 574682
GnomAD4 exome
AF:
AC:
142
AN:
1172302
Hom.:
Cov.:
20
AF XY:
AC XY:
58
AN XY:
574682
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000215 AC: 30AN: 139386Hom.: 1 Cov.: 22 AF XY: 0.000104 AC XY: 7AN XY: 67494
GnomAD4 genome
AF:
AC:
30
AN:
139386
Hom.:
Cov.:
22
AF XY:
AC XY:
7
AN XY:
67494
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 26, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2023 | KCNC3: PP2, PP3, BS1 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 19, 2023 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2024 | The c.23C>G (p.S8W) alteration is located in exon 1 (coding exon 1) of the KCNC3 gene. This alteration results from a C to G substitution at nucleotide position 23, causing the serine (S) at amino acid position 8 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Apr 14, 2017 | - - |
KCNC3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 23, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
.;N
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
1.0
.;D
Vest4
MutPred
Loss of phosphorylation at S8 (P = 0.0187);Loss of phosphorylation at S8 (P = 0.0187);
MVP
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at